- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imaging utilization increaseswhere radiologists wane
Diagnostic imaging utilization rates don’t just swing wildly across the 10 Medicare regions.
Diagnostic imaging utilization rates don’t just swing wildly across the 10 Medicare regions. According to Thomas Jefferson University researchers, the areas with the highest utilization rates also have the lowest percentage of radiologists.
TJU radiology chair Dr. Vijay Rao and colleagues looked at trends in noninvasive imaging services over a five-year period ending in 2006 using the Medicare Part B feefor- service database. In 2006, utilization rates per 1000 beneficiaries ranged from a high of 4532 in the Atlanta region to a low of 2901 in the Seattle region. Radiologists’ share of the imaging services provided ranged from 69% in the Boston region to a low of 58% in the Atlanta region. Plotting radiologist share against the overall utilization rates showed that the higher the utilization rate, the lower the percentage of radiologists providing the services. Rao released findings at the 2008 RSNA meeting.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
